Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2004
05/13/2004US20040093643 Preparing transgenic plants for use as bioreactors in generation of therapeutic proteins; pharmacogenetics
05/13/2004US20040093642 Preparing and propagating transgenic monocotyledons comprising nucleotide sequences code polypeptides associated with controlling endosperm size, development and viability; enhancing nutrient content of seeds
05/13/2004US20040093641 Regulating metabolism by modifying the level of trehalose-6-phosphate
05/13/2004US20040093640 Fungal resistant transgenic plants
05/13/2004US20040093639 Using genetic engineered enzymes; Dna sequences; reducing amount of fertilizer for plant growth
05/13/2004US20040093638 Enhancing triglyceride biosynthesis in leaf and seed oils of plants via overexpression of acetyl-coa cacrboxylase in chloroplasts
05/13/2004US20040093637 Hybrid Bacillus thuringiensis delta-endotoxins with novel broad-spectrum insecticidal activity
05/13/2004US20040093636 Transformation and expression vector for stable transfer of DNA coding microbiocide into chloroplast and generating disease resistant plants
05/13/2004US20040093635 Nucleotide sequences coding polypeptide for transformation and generation of oomycete/disease resistant potato crops
05/13/2004US20040093634 Deoxymugineic acid synthase and gene thereof
05/13/2004US20040093633 Comprises nucleotide sequences coding resistance to powdery mildew-8 gene for transformation and generation of plants tolerant of fungal diseases
05/13/2004US20040093632 Genetic manipulation of condensed tannins
05/13/2004US20040093630 Zebrafish huc promoter capable of directing neuron-specific expression of structural genes, transgenic animal having huc promoter and its generation, and method for screening neuronal mutant animals using the transgenic animal
05/13/2004US20040093628 Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates
05/13/2004US20040093627 Methods
05/13/2004US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity
05/13/2004US20040093625 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines
05/13/2004US20040093624 Increasing implantation and surival frequency of nuclear transfer embryos via fibroblast growth factor -4 expression (FGF-4); in vitro fertilization
05/13/2004US20040093623 Non-human animal disease models
05/13/2004US20040093622 Preparing transgenic rodent expressing genetically engineered immunoglobulins for treatment hypercholesterolemia, atherosclerosis, cystic fibrosis and muscular dystrophy
05/13/2004US20040092911 Ophthalmic drug delivery device
05/13/2004US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene
05/13/2004US20040092729 Oligonucleotide sequences coding genetic suppressor elements resistant to antitumor agents; multidrug resistance in cancer cells
05/13/2004US20040092724 Transmembrane mucopolysaccharide for treatment and diagnosis of cell proliferative disorders and cancer; antitumor agents
05/13/2004US20040092722 Preparing immunoglobulin for diagnosis and treatment of cardiovascular disorders
05/13/2004US20040092717 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
05/13/2004US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders
05/13/2004US20040092711 Hybrid expression of neisserial proteins
05/13/2004US20040092709 Peptide mimics of the cytokine receptor common gamma chain and methods and compositions for making and using the same
05/13/2004US20040092474 Controlling cell proliferation; contacting cell with reporter molecules; measuring, calibrating activation
05/13/2004US20040092473 Method for nucleic acid transfection of cells
05/13/2004US20040092471 Insertion nucleic acid into genome; administering transposon; gene therapy
05/13/2004US20040092468 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
05/13/2004US20040092467 Biological carriers for the delivery of proteins or peptides
05/13/2004US20040092466 A nucleotide of 8-80 nucleobases specifically hybridizes with the nucleic acid which encodes an aggrecanase to inhibit its expression; Alzheimer's Disease; kits; diagnosis/medical; screening tests
05/13/2004US20040092465 Modulation of huntingtin interacting protein 1 expression
05/13/2004US20040092464 Antisense agents for gene expression inhibition; primers for diagnosis; drug screening; treating diseases or disorders related to dysregulation of cellular apoptosis
05/13/2004US20040092463 PIM-1 is a protein serine/threonine kinase predominantly expressed in hematopoietic tissues; antisense agents for PIM-1 inhibition; treating hyperproliferative diseases; kits; drug screening; diagnostic primers
05/13/2004US20040092462 Receptors for lysophosphatidic acid (LPA), aka endothelial differentiation genes (EDG); gene expression inhibition of EDG via antisense agents; drug screening; diagnostic probes; hyperproliferative disorders
05/13/2004US20040092461 Modulation of phosphodiesterase 1B expression
05/13/2004US20040092444 Neuroprotective synergy of erythropoietin and insulin-like growth factor
05/13/2004US20040092441 Tyrosine kinase modulators
05/13/2004US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease
05/13/2004US20040092021 Methods for generating hypermutable yeast
05/13/2004US20040092020 Plant expression vector comprising non-plant 3' termination sequence for transcription of heterologous nucleotide sequences in crops; disease resistant plants
05/13/2004US20040092019 Particle-mediated transformation of animal tissue cells
05/13/2004US20040092018 Using transposon insertion to generate library of genetic mutations
05/13/2004US20040092017 Binary viral expression system in plants
05/13/2004US20040092016 Enhanced homologous recombination mediated by lambda recombination proteins
05/13/2004US20040092009 Codon optimized synthetic plasmids
05/13/2004US20040092008 Recombinant AAV vectors for gene therapy of hemophilia A
05/13/2004US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine
05/13/2004US20040092006 Applying activating compound to surface of detector
05/13/2004US20040092005 Using acid/alkali hydrolysis to recycle matrix comprising oligonucleotides immobilized via acid-amido bonding; reusable solid support for nucleotide sequences analysis
05/13/2004US20040091998 Method for microbial production of difructose anhydride III , micro-organism used therefor and enzyme with inulase II activity and dna sequences coding therefor
05/13/2004US20040091996 Genetically engineered virus which propagates specifically in tumor cells and codes angiogensis inhibitors; antitumor/antiproliferative agents
05/13/2004US20040091995 Replication defective poxvirus coding granulocyte-monocyte-colony stimulating factor (GM-CSF) for treatment and prevention of neutropenia and tumor disorders; antitumor/antiproliferative agents
05/13/2004US20040091990 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
05/13/2004US20040091989 Genetically engineered heat stable glutamate oxidase for use in food processing and treatment of nervous system disorders; flavors
05/13/2004US20040091988 Methods and compositions employing a novel stearoyl-coa desaturase-hscd5
05/13/2004US20040091983 Secondary liquefaction in ethanol production
05/13/2004US20040091980 Method for producing L-leucine
05/13/2004US20040091979 Biosynthesis using enzymes
05/13/2004US20040091976 Fermentation of genetic engineered microorganisms; gastrointestinal disorders, antiallergens, inflammatory bowel disorders, antiarthritic agents
05/13/2004US20040091975 Midecamycin biosynthetic genes
05/13/2004US20040091974 Anti-hla-dr antibody
05/13/2004US20040091973 Process for selecting anti-angiognesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
05/13/2004US20040091972 Membrane protein for diagnosis, prevention and treatment cell proliferative disorders
05/13/2004US20040091971 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine
05/13/2004US20040091966 Polypeptide regulation by conditional inteins
05/13/2004US20040091965 Regulation of human adam-ts-like protein
05/13/2004US20040091964 Modified proteins, isolated novel peptides,and uses thereof
05/13/2004US20040091960 Novel physiologically active peptides and use thereof
05/13/2004US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer
05/13/2004US20040091958 Expression vector coding glyceraldehyde-3-phosphate dehydrogenase for transformation of phaffa and biosyntnhesis of astaxanthin
05/13/2004US20040091955 Process and compositions for peptide, protein and peptidomimetic synthesis
05/13/2004US20040091950 Vectors for use in transposon-based dna sequencing methods
05/13/2004US20040091939 Device and method for detection of multiple analytes
05/13/2004US20040091926 Comprises nucleotide sequences coding calcineurin-like protein phosphatase 1 (CLPP1) for diagnosis, prevention and treatment of inflammation, cancer, arteriosclerosis and psoriasis
05/13/2004US20040091925 Nucleic acid archiving
05/13/2004US20040091924 Method for detecting base mutation
05/13/2004US20040091921 Method for gene expression analysis and kit for gene expression analysis
05/13/2004US20040091920 Method of constructing a mutant DNA library and use thereof
05/13/2004US20040091919 Antisense modulation of superoxide dismutase 1, soluble expression
05/13/2004US20040091918 Methods and kits for synthesis of siRNA expression cassettes
05/13/2004US20040091917 Simplified use of 5' ends of RNAs for cloning and cDNA library construction
05/13/2004US20040091913 Composition and method for imaging cells
05/13/2004US20040091912 Diagnostic method
05/13/2004US20040091911 Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same
05/13/2004US20040091910 Isolation of RNA, DNA and proteins from formalin-fixed paraffin-embedded tissue specimens
05/13/2004US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof
05/13/2004US20040091904 Methods for identifying compounds that bind to a target
05/13/2004US20040091902 Modified reductase and its gene
05/13/2004US20040091900 Materials and methods for providing plants with increased resistance to environmental stress
05/13/2004US20040091898 Polynucleotide sequence encoding phosphatidylinositol(PI3k) protein; useful in reducing cell death after trauma and overcoming insulin resistance
05/13/2004US20040091897 Disease associated polymorphism in the ctla-4 locus
05/13/2004US20040091896 Having plurality of 5-6 membered unsaturated rings linked together by way of linker chains to form a backbone, at least some of 5-6 membered unsaturated rings carrying a ligand; DNA mimics, supports for use in oligonucleotide production
05/13/2004US20040091895 Human sprouty-4 polypeptide
05/13/2004US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
05/13/2004US20040091891 Protein of given sequence which has the 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase activity; prephenate dehydratase and chorismate mutase; useful for improvement of productivity of aromatic amino acids